Attention: This is just to inform you that we endorse conferences that are either organised by our member societies and/or networks as well as conferences where EUFEPS will be participating actively. If we endorse or co-sponsor a conference you will find them in our calendar.

24-26 May, 2018, Titania Hotel, Athens Oral Drug absorption: Science & Regulation From properties and processes (dissolution, solubility, supersaturation, precipitation, permeability, carriers, IVIVC, BCS, BDDCS, biowaivers) To the classical/ most innovative medicines (minitablets, 3D printing, controlled release, nanoscinece, gene delivery) and their PK - PD evaluation (clinical studies,...

Discussion Slides and Abstract Submission: click here fore more information. Scope and aim Assessment of bioequivalence is considered one of the key elements in the development and registration of new medicinal products. In case of generic drugs, it is the essential basis for product approvals worldwide. At the same time, it is obvious that the regulations and jurisdictions still differ to...

The regulatory and technical landscape of the pharmaceutical field is rapidly evolving from one focused predominantly on development of small molecules, using well established manufacturing technologies towards an environment in which biologicals and complex modalities are being developed using advanced science and technology coupled with the application of modern Quality by Design (QbD)...

EUFEPS is also proud to announce that Women in Pharmaceutical Sciences Platform WIPS has been established during the last EUFEPS Council which took place in Hungary to support women PhD students and post-doctoral researchers by facilitating their travels and participation in symposia. The first EUFEPS WIPS grants will be awarded during the Annual Meeting in Athens so I suggest you to join this...

This convening, on November 9, 2016, in New York, USA, is co-sponsored by EUFEPS and aims to identify the best approaches for complex drug development and regulation, to outline outstanding challenges in the assessment of complex drug equivalence and consequences for interchangeability of products, to address whether the regulatory approaches for biosimilars should be used as models for other...

Veterinary medicines account for a substantial portion of the production, sale, and consumption of medicines in Europe, and probably world-wide. This calls our attention to the fact that only healthy farm animals can ensure safe and sufficient livestock products to meet the growing demand for animal protein. Human and veterinary medicine share many common features - expressed and symbolised by...